Management of infusion reactions to systemic anticancer therapy: ESMO Clinical Practice Guidelines.

about

Management of infusion reactions to systemic anticancer therapy: ESMO Clinical Practice Guidelines.

Item

http://www.wikidata.org/entity/Q50205188

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Management of infusion reactio ...... Clinical Practice Guidelines.

@en

Management of infusion reactio ...... Clinical Practice Guidelines.

@nl

type

Item

label

Management of infusion reactio ...... Clinical Practice Guidelines.

@en

Management of infusion reactio ...... Clinical Practice Guidelines.

@nl

prefLabel

Management of infusion reactio ...... Clinical Practice Guidelines.

@en

Management of infusion reactio ...... Clinical Practice Guidelines.

@nl

P1476

Management of infusion reactio ...... O Clinical Practice Guidelines

@en

P2093

A Cervantes

http://www.w3.org/2001/XMLSchema#string

ESMO Guidelines Committee

http://www.w3.org/2001/XMLSchema#string

I Blasco

http://www.w3.org/2001/XMLSchema#string

K Jordan

http://www.w3.org/2001/XMLSchema#string

L García Fabregat

http://www.w3.org/2001/XMLSchema#string

P2860

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer.

Anaphylactoid reactions in children receiving high-dose intravenous cyclosporine for reversal of tumor resistance: the causative role of improper dissolution of Cremophor EL

Pembrolizumab for the treatment of non-small-cell lung cancer

Management and preparedness for infusion and hypersensitivity reactions.

Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose.

Inter-relationships of paclitaxel disposition, infusion duration and cremophor EL kinetics in cancer patients.

Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study.

The diagnosis and management of anaphylaxis practice parameter: 2010 update.

P304

iv100-iv118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDX216

http://www.w3.org/2001/XMLSchema#string

P433

suppl_4

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

S Roselló

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28881914

http://www.w3.org/2001/XMLSchema#string